Pharmac proposing to improve treatment options for New Zealanders who have experienced serious cardiovascular events

Imported from official source

Announcement

Safety Classified by Officially

Pharmac is seeking feedback on a proposal to fund prasugrel, a medicine that helps reduce the risk of blood clots and reduce the risk of serious heart-related events.

The proposal would make prasugrel available to people who have had a heart attack or undergone certain procedures, such as angioplasty or stent placement.

Michaela Lion, Pharmac’s Manager, Pharmaceutical Funding, says the proposal would provide another funded treatment option for people who need medicines to prevent potentially life-threatening blood clots.

“After a heart attack or some heart procedures, people are often prescribed medicines that help stop blood clots from forming and reduce the risk of further cardiovascular events,” says Lion.

“We know that not every medicine works the same way for every person. For some people, currently funded treatment options may not be suitable because of allergy, intolerance, or reduced effectiveness.

Funding prasugrel would provide clinicians with another option when deciding on the treatment that best meets the person's needs. 

Prasugrel was previously funded in New Zealand but became unavailable after it was discontinued by its supplier in 2021. 

“This proposal would make the medicine available again and increase treatment choice for around 4000 people at risk of serious heart-related events,” Lion says. 

Prasugrel is taken once a day, which may make treatment easier for some people.

Prasugrel is a medicine that helps reduce the risk of blood clots from forming. It is usually taken with aspirin to reduce the risk of serious heart-related events, such as another heart attack or stroke. A heart attack or stroke may occur when a blood vessel in the heart or brain is blocked by a blood clot. Prasugrel reduces the chance that a harmful blood clot will form by preventing certain cells in the blood from clumping or sticking together. Prasugrel may also increase the chance for serious bleeding in some people.

This is an extract. The publication continues at the source.

© Pharmac, licensed under CC BY 4.0. Licence

Read the original at the source: https://www.pharmac.govt.nz/news-and-resources/news/pharmac-proposing-to-improve-treatment-options-for-new-zealanders-who-have-experienced-serious-cardiovascular-events

Officially imported this from Pharmac’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Pharmac — imported from official source
Official source
https://www.pharmac.govt.nz/news-and-resources/news/rss RSS
Imported
November 12, 2026 01:31
Versions
1 recorded
Identity
https://www.pharmac.govt.nz/news-and-resources/news/pharmac-proposing-to-improve-treatm...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.